Metis Global Partners’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.6M | Sell |
18,374
-5,746
| -24% | -$502K | 0.04% | 359 |
|
|
2025
Q1 | $1.65M | Buy |
24,120
+1,926
| +9% | +$132K | 0.05% | 349 |
|
|
2024
Q4 | $1.73M | Buy |
22,194
+1,028
| +5% | +$79.9K | 0.05% | 319 |
|
|
2024
Q3 | $1.42M | Buy |
21,166
+2,684
| +15% | +$180K | 0.04% | 369 |
|
|
2024
Q2 | $2.1M | Buy |
18,482
+317
| +2% | +$35.9K | 0.07% | 231 |
|
|
2024
Q1 | $2.52M | Buy |
18,165
+221
| +1% | +$30.7K | 0.09% | 199 |
|
|
2023
Q4 | $2.23M | Sell |
17,944
-1,384
| -7% | -$172K | 0.09% | 206 |
|
|
2023
Q3 | $1.8M | Buy |
19,328
+2,526
| +15% | +$236K | 0.09% | 239 |
|
|
2023
Q2 | $2.16M | Buy |
16,802
+146
| +0.9% | +$18.8K | 0.12% | 184 |
|
|
2023
Q1 | $1.94M | Buy |
16,656
+3,576
| +27% | +$415K | 0.12% | 170 |
|
|
2022
Q4 | $1.48M | Buy |
13,080
+5,666
| +76% | +$642K | 0.13% | 179 |
|
|
2022
Q3 | $597K | Buy |
7,414
+391
| +6% | +$31.5K | 0.1% | 240 |
|
|
2022
Q2 | $524K | Buy |
7,023
+891
| +15% | +$66.5K | 0.08% | 276 |
|
|
2022
Q1 | $784K | Buy |
6,132
+2,752
| +81% | +$352K | 0.09% | 193 |
|
|
2021
Q4 | $453K | Buy |
+3,380
| New | +$453K | 0.13% | 179 |
|